The Adiponectin-AdipoR1 Axis Mediates Tumor Progression and Tyrosine Kinase Inhibitor Resistance in Metastatic Renal Cell Carcinoma

The survival of patients diagnosed with metastatic renal cell carcinoma (RCC) is still limited and the current targeted therapies are only partially effective. Herein, we investigated the clinical value and functions of adiponectin receptors (AdipoR1 and AdipoR2) in metastatic renal cell carcinoma (...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neoplasia
Main Authors: Sun, Guangxi, Zhang, Xingming, Liu, Zhenhua, Zhu, Sha, Shen, Pengfei, Zhang, Haoran, Zhang, Mengni, Chen, Ni, Zhao, Jinge, Chen, Junru, Liu, Jiandong, Dai, Jindong, Wang, Zhipeng, Zhu, Xudong, Wang, Yufang, Zeng, Hao
Formato: Artigo
Idioma:Inglês
Publicado em: Neoplasia Press 2019
Assuntos:
Original article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6700451/
https://ncbi.nlm.nih.gov/pubmed/31401413
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2019.07.004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados